REILLY FINANCIAL ADVISORS, LLC - INTEC PHARMA LTD JERUSALEM ownership

INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 53 filers reported holding INTEC PHARMA LTD JERUSALEM in Q2 2019. The put-call ratio across all filers is 26.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
REILLY FINANCIAL ADVISORS, LLC ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q3 2020$1,0000.0%5,0000.0%0.00%
Q2 2020$1,0000.0%5,0000.0%0.00%
Q1 2020$1,000
-66.7%
5,0000.0%0.00%
Q4 2019$3,000
-25.0%
5,0000.0%0.00%
Q3 2019$4,000
-81.8%
5,0000.0%0.00%
-100.0%
Q2 2019$22,000
-40.5%
5,0000.0%0.00%
-40.0%
Q1 2019$37,000
-2.6%
5,0000.0%0.01%
-16.7%
Q4 2018$38,0005,0000.01%
Other shareholders
INTEC PHARMA LTD JERUSALEM shareholders Q2 2019
NameSharesValueWeighting ↓
Prosight Management, LP 815,789$3,541,0001.78%
MEITAV INVESTMENT HOUSE LTD 2,460,136$10,651,0000.71%
DAFNA Capital Management LLC 415,989$1,805,0000.68%
KNOTT DAVID M 259,377$1,126,0000.48%
SECTORAL ASSET MANAGEMENT INC 879,000$3,815,0000.46%
SPHERA FUNDS MANAGEMENT LTD. 620,000$2,691,0000.37%
ESSEX INVESTMENT MANAGEMENT CO LLC 283,434$1,230,0000.17%
Harel Insurance Investments & Financial Services Ltd. 624,809$2,711,0000.14%
Avoro Capital Advisors LLC 820,000$3,559,0000.12%
MENTA CAPITAL LLC 52,792$229,0000.10%
View complete list of INTEC PHARMA LTD JERUSALEM shareholders